The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSTN.L Regulatory News (HSTN)

  • There is currently no data for HSTN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - [Hansteen Holdings Plc]

19 Dec 2019 15:34



Form 8.3 - [Hansteen Holdings Plc]

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Kames Capital Plc
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. 
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeHansteen Holdings plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: 
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure18/12/2019
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”NoIf YES, specify which:

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary Share
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:9,665,7302.26200.00
(2) Cash-settled derivatives: 00.0000.00
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:00.0000.00
TOTAL:9,665,7302.26200.00

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/sale Number of securitiesPrice per unit
    

(b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
     

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit
        

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
     

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)
    

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? 

Date of disclosure:19/12/2019
Contact name:Stephen Adams
Telephone number:0131 549 6714 For any issues relating to this disclosure please contact 0131 549 3288 or kamestradeoperationsmb@kamescapital.com

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.


Date   Source Headline
18th Mar 20196:13 pmRNSHolding(s) in Company
6th Mar 20195:17 pmRNSHolding(s) in Company
1st Mar 20194:20 pmRNSHolding(s) in Company
25th Feb 20195:54 pmRNSHolding(s) in Company
13th Feb 20198:00 amRNSNotice of Results
24th Dec 20187:00 amRNS£86.5 million of property disposals
19th Dec 20189:40 amRNSHolding(s) in Company
23rd Nov 20185:31 pmRNSHolding(s) in Company
1st Oct 20187:00 amRNSBoard Change
24th Sep 20185:06 pmRNSHolding(s) in Company
6th Sep 20187:00 amRNSRE: Potential disposal
24th Aug 20182:38 pmRNSHolding(s) in Company
22nd Aug 20187:00 amRNSHalf-year Report
6th Aug 20187:00 amRNSHansteen acquires £53.7m mixed use UK portfolio
6th Aug 20187:00 amRNSST. MODWEN RELEASES £47M VIA SALE OF 34 ASSETS
2nd Aug 20183:57 pmRNSHolding(s) in Company
31st Jul 20185:00 pmRNSHolding(s) in Company
26th Jul 20182:21 pmRNSPotential Disposal
25th Jul 20185:11 pmRNSHolding(s) in Company
20th Jul 20185:10 pmRNSHolding(s) in Company
12th Jul 20189:01 amRNSHolding(s) in Company
12th Jul 20188:00 amRNSNotice of Results
4th Jul 20183:56 pmRNSHolding(s) in Company
12th Jun 20182:17 pmRNSResult of AGM
11th May 20184:06 pmRNSHolding(s) in Company
10th May 20188:00 amRNSHolding(s) in Company
1st May 201811:45 amRNSCourt approval and proposed return of capital
27th Apr 20184:25 pmRNSAnnual Report and Accounts & Notice of 2018 AGM
20th Apr 20189:11 amRNSDirector/PDMR Shareholding
13th Apr 20184:48 pmRNSDirector/PDMR Shareholding
11th Apr 20182:34 pmRNSAnnouncement of the General Meeting poll results
9th Apr 20185:12 pmRNSCorrection - Employee Benefit Trust Share Purchase
5th Apr 201812:30 pmRNSEmployee Benefit Trust Share Purchase
4th Apr 20183:15 pmRNSHolding(s) in Company
27th Mar 20185:00 pmRNSDirector/PDMR Shareholding
27th Mar 20187:00 amRNSDisposals
20th Mar 20187:01 amRNSProposed Return of £145M of Capital & Notice of GM
20th Mar 20187:00 amRNSFinal Results
14th Mar 20182:51 pmRNSHolding(s) in Company
13th Mar 20187:00 amRNSCompulsory Purchase of Saltley Business Park
22nd Feb 201810:53 amRNSDirectorate Change
22nd Feb 20187:00 amRNSDirectorate Change
19th Feb 20188:00 amRNSNotice of Results - Replacement
7th Feb 20183:02 pmRNSHolding(s) in Company
5th Feb 20187:00 amRNSHansteen sells IMPT portfolio for £116 million
15th Jan 20188:00 amRNSNotice of Results
5th Jan 20184:18 pmRNSHolding(s) in Company
4th Jan 20185:30 pmRNSHolding(s) in Company
3rd Jan 20183:32 pmRNSHolding(s) in Company
27th Dec 20178:15 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.